FDA.reportPublic FDA data

faricimab-svoa 6 MG per 0.05 ML Injection

RxCUI
2591588
RxNorm name
faricimab-svoa 6 MG per 0.05 ML Injection
Display name
faricimab-svoa 6 MG per 0.05 ML Injection
Full name
faricimab-svoa 6 MG per 0.05 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761235Vabysmofaricimab-svoa351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VABYSMOFARICIMABGenentech, Inc.04cc9ef7-c02a-4e92-a655-0062674e84872026-04-15Warnings, Adverse reactionsExact identifier
rxcui: 2591588

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
04cc9ef7-c02a-4e92-a655-0062674e8487faricimab-svoa 6 MG per 0.05 ML InjectionSY11These highlights do not include all the information needed to use VABYSMO safely and effectively. See full prescribing information for VABYSMO. VABYSMO ® (faricimab-svoa) injection, for intravitreal use Initial U.S. Approval: 202220260415
04cc9ef7-c02a-4e92-a655-0062674e84870.05 ML faricimab-svoa 120 MG/ML InjectionSCD11These highlights do not include all the information needed to use VABYSMO safely and effectively. See full prescribing information for VABYSMO. VABYSMO ® (faricimab-svoa) injection, for intravitreal use Initial U.S. Approval: 202220260415
04cc9ef7-c02a-4e92-a655-0062674e8487faricimab-svoa 6 MG in 0.05 ML InjectionPSN11These highlights do not include all the information needed to use VABYSMO safely and effectively. See full prescribing information for VABYSMO. VABYSMO ® (faricimab-svoa) injection, for intravitreal use Initial U.S. Approval: 202220260415